Macrolide-resistant Mycoplasma pneumoniae
in humans, Ontario, Canada, 2010-2011.
Isothermal detection of Mycoplasma pneumoniae
directly from respiratory clinical specimens.
Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae
pneumonia: a review of the japanese literature.
Infectious causes include influenza A and B, coxsackievirus, Epstein-Barr virus, herpes simplex, parainfluenza, adenovirus, echovirus, enterovirus, human immunodeficiency virus, cytomegalovirus, varicella-zoster, Mycoplasma pneumoniae
, Legionella pneumophila, tularemia, Streptococcus pneumoniae, Salmonella, E.
Reyes, "Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae
pneumonia," The American Journal of Medicine, vol.
Influenza coinfected with Mycoplasma pneumoniae
(2.9%) was found in influenza-positive children, which is an important pathogen of ARI and community-acquired pneumonia in children .
Quero, "Mycoplasma pneumoniae
pericarditis and cardiac tamponade in a ten-year-old girl," The Pediatric Infectious Disease Journal, vol.
Izumikawa, "Clinical features of severe or fatal Mycoplasma pneumoniae
pneumonia," Frontiers in Microbiology, vol.
Moghaddam, "Respiratory tract infections during the 2011 Mycoplasma pneumoniae
epidemic," European Journal of Clinical Microbiology and Infectious Diseases, vol.
The etiology of ARI involves among other microorganisms the Streptococcus pneumoniae, Haemophilus influenza, Klebsiella pneumoniae, Staphylococcus aureus, and viruses such as Syncitial Respiratory Virus, influenza a and b, parainfluenza 1, 2 and 3, adenovirus, and atypical germs such as Chlamydophila pneumoniae (CP) and Mycoplasma pneumoniae
The collected specimens were subjected to common microorganism detection: bacterial detection by the conventional bacterial culture, Mycoplasma pneumoniae
(Mp) detection by polymerase chain reaction (PCR) assay (Shanghai Shen Yousheng Biotech, Shanghai, China) and virus detection by Chemicon direct immunofluorescence assay (DIA).
(18) Mycoplasma pneumoniae
, which typically produces a mild "walking" pneumonia, has demonstrated increasing resistance to macrolide antibiotics (likely associated with the widespread use of azithromycin), with wide geographic variability, ranging from 7% in Seattle to 50% in New Jersey.